There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on GlycoMimetics (GLYC – Research Report) and Alignment Healthcare (ALHC – Research Report) with bullish sentiments.
GlycoMimetics (GLYC)
TD Cowen analyst Boris Peaker maintained a Buy rating on GlycoMimetics today. The company’s shares closed last Friday at $1.30.
According to TipRanks.com, Peaker is a 5-star analyst with an average return of
GlycoMimetics has an analyst consensus of Moderate Buy, with a price target consensus of $8.00.
See Insiders’ Hot Stocks on TipRanks >>
Alignment Healthcare (ALHC)
In a report released today, Nathan Rich from Goldman Sachs maintained a Buy rating on Alignment Healthcare. The company’s shares closed last Friday at $6.15, close to its 52-week low of $4.88.
According to TipRanks.com, Rich is a 3-star analyst with an average return of
Alignment Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $8.75.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on GLYC:
